Author Question: The newest FDA-approved class of antidepressant drugs that don't typically induce sedation or ... (Read 82 times)

Mimi

  • Hero Member
  • *****
  • Posts: 542
The newest FDA-approved class of antidepressant drugs that don't typically induce sedation or anticholinergic side effects
 
  a. are selective serotonin reuptake inhibitors
  b. have been shown to increase the symptoms of obsessive-compulsive disorders
  c. have a higher abuse potential than earlier antidepressants
  d. all of the above

Question 2

The most significant problem associated with the use of lithium in the treatment of affective disorders is
 
  a. its low therapeutic index
  b. its tendency to be toxic to the liver
  c. its expense as a prescription medication
  d. the requirement of maintaining low sodium intake for it to be effective



Kimmy

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

a

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Dogs have been used in studies to detect various cancers in human subjects. They have been trained to sniff breath samples from humans that were collected by having them breathe into special tubes. These people included 55 lung cancer patients, 31 breast cancer patients, and 83 cancer-free patients. The dogs detected 54 of the 55 lung cancer patients as having cancer, detected 28 of the 31 breast cancer patients, and gave only three false-positive results (detecting cancer in people who didn't have it).

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library